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Oscillatory shear stress increases smooth muscle
cell proliferation and Akt phosphorylation
Masae Haga, MD,a,b Akimasa Yamashita, MD, PhD,a,b Jacek Paszkowiak, MD,a,b,c Bauer E. Sumpio,
MD, PhD,a,b and Alan Dardik, MD, PhD,a,b,c New Haven, West Haven, and Waterbury, Conn
Purpose: Hemodynamic forces affect smooth muscle cell (SMC) proliferation and migration both in vitro and in vivo.
However, the effects of oscillatory shear stress (SS) on SMC proliferation and signal transduction pathways that control
survival are not well described.
Methods: Bovine aortic SMC were exposed to arterial levels of oscillatory SS (14 dyne/cm2) with an orbital shaker; control
cells were exposed to static conditions (0 dyne/cm2). Cell number and 3[H]thymidine incorporation were measured after
1, 3, or 5 days of SS. Activation of the Akt pathway was assessed with the Western blot technique. Specificity of the
phosphatidylinositol 3-kinase (PI3K) pathway was determined with the Western blot technique with the inhibitors
LY294002 (10 mol/L) or wortmannin (25 nmol/L).
Results: Arterial levels of oscillatory SS increased SMC cell number by 20.1  3.7% and 3[H]thymidine incorporation by
33.4%  6.8% at 5 days. To identify whether SS increased activity of the SMC survival pathway, Akt activation was
measured. SMC exposed to SS demonstrated increased Akt phosphorylation compared with control cells, with maximal
phosphorylation at 60 minutes. Both PI3K inhibitors specifically inhibited the increase in Akt phosphorylation in SMC
exposed to oscillatory SS.
Conclusion: SMC directly respond to oscillatory SS by increasing DNA synthesis, proliferation, and activation of the
PI3K-Akt signal transduction pathway. These results suggest a mechanism of SMC survival and proliferation in response
to endothelial-denuding arterial injury. (J Vasc Surg 2003;37:1277-84.)
Although the entire blood vessel is subjected to hemo-
dynamic forces, eg, blood pressure and cyclic strain, only
endothelial cells are ordinarily exposed to arterial levels of
pulsatile shear stress (SS), the lateral frictional force of the
flowing blood on the endothelial cell apical membrane.
Nevertheless, altered SS can affect smooth muscle cells
(SMC) in vivo. For example, SS affects neointimal hyper-
plasia and SMC proliferation in vascular prosthetic grafts1-4
and SMC morphology in vein grafts.5 Alterations in SS and
hemodynamic forces regulate SMC proliferation and the
signal transduction pathways that control proliferation in
normal arteries as well.6,7
Several studies have examined the effects of hemody-
namic forces on SMC in vitro. For example, work by our
laboratory and others demonstrated that cyclic strain in-
creases protein synthesis and affects proliferation in
SMC.8-11 Cyclic strain also affects the intracellular signal
transduction pathways, eg, the adenylate cyclase path-
way,12,13 the protein kinase A and C pathways,13,14 the
mitogen activated protein kinase (MAPK) pathway,15 and
the phosphatidylinositol 3-kinase (PI3K)–Akt pathway.16
Also, stretch increases platelet-derived growth factor recep-
tor- activation in SMC.17
Of particular note, SMC can respond to SS as well.
With laminar flow models, it has been demonstrated that SS
increases expression of basic fibroblast growth factor, an-
giotensin converting enzyme, and inducible macrophage-
type nitric oxide synthase,18,19 production of transforming
growth factor–1, cyclic guanosine monophosphate, tissue
plasminogen activator, and nitric oxide,20-22 and release of
fibroblast growth factor 2, prostaglandin E2, and prosta-
glandin I2.
23,24 SS also increases migration in SMC.25,26
Inasmuch as oscillatory SS may represent a new model
of disturbed, possibly nonlaminar, SS that may correlate
more clearly with forces present in vivo,27,28 we examined
the effects of oscillatory SS on SMC proliferation and
activation of the intracellular signal transduction pathways
that control survival.
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METHODS
Cell culture and shear stress application. Bovine
aortic SMC were obtained as described.29 In brief, bovine
thoracic aortas were obtained from a local slaughterhouse,
cleaned of adventitia, and the endothelial cells were scraped
off gently. The aorta was minced into small pieces that were
cultured in 20% fetal bovine serum for 4 hours, then in 10%
FBS for 4 or 5 days until SMC migrated away from the
tissue.
Cells were cultured in Dulbecco modified Eagle me-
dium F-12 (GIBCO BRL, Life Technologies, Gaithers-
burg, Md) supplemented with 10% fetal calf serum, 5
g/mL of deoxycytidine/thymidine (Sigma, St Louis,
Mo), and antibiotic agents (penicillin, 100 U/L; strepto-
mycin, 100 /mL; amphotericin B, 250 ng/mL; all from
Gibco-BRL) at 37°C in a humidified incubator with 5%
carbon dioxide. SMC identity was confirmed with both
typical anatomy and immunoreactivity with -actin (Sig-
Fig 1. Increased smooth muscle cell (SMC) proliferation in response to oscillatory shear stress (SS). Synchronized
SMC were exposed to oscillatory SS (14 dyne/cm2) for up to 5 days or to static conditions, and cell numbers were
counted with an automatic counter. A, Representative experiment. Primary group, number of SMC immediately after
seeding and before synchronization with serum withdrawal for 24 hours; 0 day, primary group after synchronization
and at start of SS exposure. B, Summary of three independent experiments. Error bars reflect SEM.
JOURNAL OF VASCULAR SURGERY
June 20031278 Haga et al
ma). Cells from passages 3 to 6 were seeded on collagen
I–coated six-well plates after detachment with trypsin, and
then were serum-starved for 24 hours before exposure to
arterial levels of oscillatory SS (14 dyne/cm2). Cells were
exposed to oscillatory SS28 with an orbital shaker (LabLine,
Melrose Park, Ill) in the presence of 20% serum, as well as
the additional presence or absence of PI3K inhibitors
LY294002 (10 mol/L) or wortmannin (25 nmol/L).
Cell counting. Cells were detached with trypsin or
ethylenediamine tetraacetic acid, and an aliquot was
counted with an automatic counter (Model ZM; Coulter
Electronics, Hialeah, Fla) both before application of SS and
after 1, 3, or 5 days of exposure to SS.
Thymidine incorporation. After serum-starvation
for 24 hours, cells were placed in medium containing 20%
fetal bovine serum and 3[H]thymidine (1 Ci/mL) and
were exposed to SS (0 or 14 dyne/cm2) for up to 5 days.
Experiments were performed in parallel with cell counts of
the same passage cells. After SS treatment, trichloroacetic
acid–precipitable proteins were solublized with 0.2N
NaOH and counted with a scintillation counter (Beck-
mann, Fullerton, Calif).
Fig 2. Increased smooth muscle cell DNA synthesis in response to oscillatory shear stress. Synchronized smooth
muscle cells were exposed to oscillatory shear stress (14 dyne/cm2) for up to 5 days or to static conditions in the
presence of 3[H]thymidine; trichloroacetic acid–precipitable protein was counted with a scintillation counter. A,
Representative experiment. B, Summary of three independent experiments. Error bars reflect SEM.
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Immunoblot technique. After exposure to SS, cells
were washed with ice-cold phosphate-buffered saline solu-
tion and scraped in lysis buffer containing 50 mmol/L of
HEPES (N-2-hydroxyethylpiperazine-N-2-ethanesulfonic
acid), 150 mmol/L of sodium chloride, 10% glycerol, 1%
Triton X-100, 1.5 mmol/L of sodium orthovanadate, 1
mmol/L of phenylmethylsulfonyl fluoride, and 10 g/mL
leupeptin. Cell lysate was centrifuged to collect superna-
tant, and equal amounts of protein (30 g per lane; BioRad
protein assay system; BioRad Laboratories, Hercules, Calif)
were separated with 10% sodium dodecylsulfate–polyacryl-
amide gel electrophoresis and transferred to a nitrocellulose
membrane (Amersham Life Science, Arlington Heights,
Ill). Cell lysates containing 30 g protein were loaded in
each lane and incubated with primary antibody, either
anti-Akt antibody or anti-phospho-specific Akt antibody
(Cell Signaling, Beverly, Mass), and horseradish peroxida-
se–conjugated secondary antibody (Cell Signaling), before
detection of immunoreactivity with enhanced chemilumi-
nescence (Amersham). All blots were quantified with den-
sitometry (BioImage, Ann Arbor, Mich).
Statistical analysis. Data were recorded as mean 
SEM and compared with the Mann-Whitney U test or
Kruskal-Wallis test with StatView 5.0.1 software (SAS In-
stitute, Cary, NC). P  .05 was considered significant.
RESULTS
Equal numbers of SMC were seeded onto six-well
plates and exposed to arterial levels (14 dyne/cm2) of
oscillatory SS or static conditions for up to 5 days. Cells that
were exposed to SS for 5 days increased in number by 20.1%
 3.7%, compared with static control cells (Fig 1). To
determine whether this increased cell number was due to
increased DNA synthesis, cells were exposed to 3[H]thy-
midine, and incorporation of 3[H]thymidine into trichlo-
roacetic acid–precipitable protein was determined. Cells
exposed to 14 dyne/cm2 SS for 5 days had increased uptake
and incorporation of 3[H]thymidine, by 33.4%  6.8%,
compared with control cells cultured under static condi-
tions (Fig 2).
Increased SMC numbers in the presence of SS can be
accounted for by both increased DNA synthesis and cell
Fig 3. Time course of Akt phosphorylation by shear stress in smooth muscle cells. Top, Photomicrograph of
representative experiment. Bottom, Bar graph depicts mean increase in ratio of phosphorylated to total Akt, compared
with baseline (time 0). Error bars reflect SEM. Difference between groups is significant (n 4; P .01, Kruskal-Wallis
test).
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proliferation, and increased cell survival. Inasmuch as Akt is
associated with increased cell survival,30-34 SS phosphory-
lation of Akt promotes survival in endothelial cells in
vitro,35-37 and Akt is present and phosphorylated in SMC
in response to various stimuli,16,38-47 activation of Akt by
SS in SMC was assessed. Cells that were exposed to arterial
levels of SS (14 dyne/cm2) demonstrated increased Akt
phosphorylation compared with control cells cultured un-
der static conditions, with maximal phosphorylation at 60
minutes (Fig 3). To determine the upstream pathway by
which SS phosphorylates Akt, inhibition of the upstream
activator of Akt, PI3K, with LY294002 or wortmannin,
was performed. SS-induced Akt phosphorylation was sup-
pressed with treatment with LY294002 or wortmannin
(Fig 4). These results suggest that the PI3K pathway can
mediate SS-induced Akt phosphorylation.
DISCUSSION
SMC demonstrate increased proliferation and 3[H]thy-
midine incorporation in response to oscillatory SS, and this
increase in cell proliferation is associated with increased Akt
phosphorylation. Furthermore, the increased Akt phos-
Fig 4. Specificity of Akt phosphorylation in smooth muscle cells. Top, Photomicrograph of representative experiment.
Bottom, Bar graph depicts mean increase in ratio of phosphorylated to total Akt, compared with static conditions (shear
stress, 0 dyne/cm2). Error bars reflect the SEM. Difference between groups exposed to shear stress, with or without
LY294002 or wortmannin, is significant (n  2; P  .05, Mann-Whitney U test).
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phorylation due to SS may be mediated with a PI3K-
dependent mechanism.
Our demonstration that SMC increase proliferation in
response to oscillatory SS is unexpected, because SMC may
decrease proliferation on exposure to laminar SS. Sterpetti
et al48 reported that laminar SS (9 dyne/cm2) decreases cell
proliferation and DNA synthesis at 24 hours; however, 50%
decrease in cell numbers was detected at only 3 hours,
which may reflect toxicity or additional experimental error.
Ueba et al20 also reported that laminar SS inhibits human
SMC proliferation; with a cone-and-plate viscometer, no
increase in proliferation was seen after 24 hours of SS,
compared with 68% increase in static control cells.
Several differences between our study and other reports
may account for our observed increase in SMC prolifera-
tion in response to SS. First, we used oscillatory, rather than
laminar, SS. The effects of different types of SS on SMC
proliferation may vary with the different stimuli and may be
entirely due to the type of forces applied to the cells.
However, Kraiss et al27 reported that oscillatory and lami-
nar SS activate pp70s6k to a similar extent, albeit in endo-
thelial cells. We believe that oscillatory SS may be a more
physiologically relevant model, because it more closely
approximates nonlaminar blood flow in vivo. Second, we
measured proliferation over 5 days, which we believe is a
more accurate assessment of cell proliferation than is mea-
surement at 24 hours.48 Finally, differences might exist in
serum in our cell culture medium, which may be a source of
SMC mitogens49,50 or inhibitors of proliferation.20,48
Koyama et al51 reported an increase in both SMC
proliferation and phosphorylation of the MAPK extracellu-
lar signal-regulated protein kinase (ERK) 1/2 in rat carotid
arteries after balloon injury. In addition, the hemodynamic
force cyclic strain increases both SMC proliferation and
ERK1/2 phosphorylation in SMC.13,15 Preliminary find-
ings in our laboratory indicate that oscillatory SS also
induces ERK1/2 phosphorylation in SMC (data not
shown). Our finding of increased SMC proliferation in
response to oscillatory SS is consistent with a role for
MAPK signal transduction in SMC proliferation, similar to
the increase in MAPK activation seen in response to growth
factor stimulation of SMC.52-55 In addition, early activa-
tion of SMC intracellular signal transduction pathways in
response to SS is consistent with the early increase in
3[H]thymidine incorporation (Fig 2) compared with the
slower increase in cell number (Fig 1).
The serine/threonine protein kinase Akt, also known as
protein kinase B, promotes cell survival and inhibits apo-
ptosis in several cell types and in response to various stim-
uli.30-35,56-58 SS phosphorylates Akt in endothelial cells in
vitro35-37; therefore Akt is presumed to be a pathway by
which SS inhibits apoptosis and promotes endothelial cell
survival in vivo.35,59 Akt is present and phosphorylated in
SMC in response to various stimuli.16,38-47 We demon-
strate increased SMC Akt activity in response to oscillatory
SS, suggesting that increased SMC survival may also ac-
count for the increase in cell number in response to SS, in
addition to cell proliferation. This increase in SMC Akt
activity may reflect either general or specific upregulation of
intracellular signal transduction pathways in response to
exposure to oscillatory SS. Our finding that activation of
SMC Akt is via a PI3K pathway, similar to activation in
other cell types,31,35,56-58 suggests specific activation of this
pathway in SMC by SS. Additional studies are needed to
define the regulation of these pathways and the differences
between laminar and oscillatory SS effects on SMC.
Activation of Akt in SMC has been demonstrated in
response to growth factors such as platelet-derived growth
factor,38,42,43,60 insulin-like growth factor 1,39 insu-
lin,41,45,55 thrombin,40 and heparin-binding epidermal
growth factor,47 molecules such as glucose44 and hista-
mine,46 and physical forces such as cyclic strain.16 Our
demonstration of Akt activation in response to SS provides
a potential mechanism for the observation that the PI3K-
Akt pathway is activated in vivo, leading to SMC prolifera-
tion after balloon injury of the rat carotid artery61,62 similar
to the growth factor–activated PI3K pathway leading to
proliferation in vitro.63,64 Although SMC are not ordinarily
exposed to SS in vivo, because of the overlying endothelial
layer, denuding injury may expose some SMC to arterial
levels of SS. This exposure may be sufficient to stimulate
SMC proliferation under SS conditions found in vivo.
In summary, SMC respond to oscillatory SS by increas-
ing DNA synthesis, proliferation, and activation of the
PI3K-Akt signal transduction pathways. These results sug-
gest a mechanism of SMC survival and proliferation in
response to endothelial-denuding injury in vivo.
REFERENCES
1. Kohler TR, Kirkman TR, Kraiss LW, Zierler BK, Clowes AW. Increased
blood flow inhibits neointimal hyperplasia in endothelialized vascular
grafts. Circ Res 1991;69:1557-65.
2. Kraiss LW, Kirkman TR, Kohler TR, Zierler B, Clowes AW. Shear stress
regulates smooth muscle proliferation and neointimal thickening in
porous polytetrafluoroethylene grafts. Arterioscler Thromb 1991;11:
1844-52.
3. Geary RL, Kohler TR, Vergel S, Kirkman TR, Clowes AW. Time course
of flow-induced smooth muscle cell proliferation and intimal thickening
in endothelialized baboon vascular grafts. Circ Res 1993;74:14-23.
4. Davies MG, Owens EL, Mason DP, Lea H, Tran PK, Vergel S, et al.
Effect of platelet-derived growth factor receptor- and - blockade on
flow-induced neointimal formation in endothelialized baboon vascular
grafts. Circ Res 2000;86:779-86.
5. Huynh TTT, Davies MG, Trovato MJ, Svendsen E, Hagen P-O.
Alterations in wall tension and shear stress modulate tyrosine kinase
signaling and wall remodeling in experimental vein grafts. J Vasc Surg
1999;29:334-44.
6. Mattsson EJR, Geary RL, Kraiss LW, Vergel S, Liao JK, Corson MA, et
al. Is smooth muscle growth in primate arteries regulated by endothelial
nitric oxide synthase? J Vasc Surg 1998;28:514-21.
7. Xu Q, Liu Y, Gorospe M, Udelsman R, Holbrook NJ. Acute hyperten-
sion activates mitogen-activated protein kinases in arterial wall. J Clin
Invest 1996;97:508-14.
8. Leung DYM, Glagov S, Mathews MB. Cyclic stretching stimulates
synthesis of matrix components by arterial smooth muscle cells in vitro.
Science 1976;191:475-7.
9. Sumpio BE, Banes AJ. Response of porcine aortic smooth muscle cells
to cyclic tensional deformation in culture. J Surg Res 1988;44:696-701.
10. Sumpio BE, Banes AJ, Link WG, Johnson G Jr. Enhanced collagen
production by smooth muscle cells during repetitive mechanical
stretching. Arch Surg 1988;123:1233-6.
JOURNAL OF VASCULAR SURGERY
June 20031282 Haga et al
11. Wilson E, Sudhir K, Ives HE. Mechanical strain of rat vascular smooth
muscle cells is sensed by specific extracellular matrix/integrin interac-
tions. J Clin Invest 1995;6:2364-72.
12. Mills I, Letsou G, Rabban J, Sumpio B, Gewirtz H. Mechanosensitive
adenylate cyclase activity in coronary vascular smooth muscle cells.
Biochem Biophys Res Commun 1990;171:143-7.
13. Mills I, Cohen CR, Kamal K, Li G, Shin T, Du W, et al. Strain activation
of bovine aortic smooth muscle cell proliferation and alignment: study
of strain dependency and the role of protein kinase A and C signaling
pathways. J Cell Physiol 1997;170:228-34.
14. Han O, Takei T, Basson M, Sumpio BE. Translocation of PKC isoforms
in bovine aortic smooth muscle cells exposed to strain. J Cell Biochem
2001;80:367-72.
15. Reusch EP, Chan G, Ives HE, Nemenoff RA. Activation of JNK/SAPK
and ERK by mechanical strain in vascular smooth muscle cells depends
on extracellular matrix composition. Biochem Biophys Res Comm
1997;237:239-44.
16. Chen AH, Gortler DS, Kilaru S, Araim O, Frangos SG, Sumpio BE.
Cyclic strain activates the pro-survival Akt protein kinase in bovine
aortic smooth muscle cells. Surgery 2001;130:378-81.
17. Hu Y, Bock G, Wick G, Xu Q. Activation of PDGF receptor  in
vascular smooth muscle cells by mechanical stress. FASEB J 1998;12:
1135-42.
18. Gosgnach W, Challah M, Coulet F, Michel JB, Battle T. Shear stress
induces angiotensin converting enzyme expression in cultured smooth
muscle cells: possible involvement of bFGF. Cardiovasc Res 2000;45:
486-92.
19. Gosgnach W, Messika-Zeitoun D, Gonzalez W, Philipe M, Michel JB.
Shear stress induces iNOS expression in cultured smooth muscle cells:
role of oxidative stress. Am J Physiol Cell Physiol 2000;279:C1880-8.
20. Ueba H, Kawakami M, Yaginuma T. Shear stress as an inhibitor of
vascular smooth muscle cell proliferation: role of transforming growth
factor-1 and tissue-type plasminogen activator. Arterioscler Thromb
Vasc Biol 1997;17:1512-6.
21. Papadaki M, Tilton RG, Eskin SG, McIntire LV. Nitric oxide produc-
tion by cultured human aortic smooth muscle cells: stimulation by fluid
flow. Am J Physiol 1998;274:H616-26.
22. Papadaki M, Ruef J, Nguyen KT, Li F, Patterson C, Eskin SG, et al.
Differential regulation of protease activated receptor-1 and tissue plas-
minogen activator expression by shear stress in vascular smooth muscle
cells. Circ Res 1998;83:1027-34.
23. Alshihabi SN, Chang YS, Frangos JA, Tarbell JM. Shear-stress induced
release of PGE2 and PGI2 by vascular smooth muscle cells. Biochem
Biophys Res Comm 1996;224:808-14.
24. Rhoads DN, Eskin SG, McIntire LV. Fluid flow releases fibroblast
growth factor-2 from human aortic smooth muscle cells. Arterioscler
Thromb Vasc Biol 2000;20:416-21.
25. Palumbo R, Gaetano C, Melillo G, Toschi E, Remuzzi A, Capogrossi
MC. Shear stress downregulation of platelet-derived growth factor
receptor- and matrix metalloproteinease-2 is associated with inhibi-
tion of smooth muscle cell invasion and migration. Circulation 2000;
102:225-30.
26. Redmond EM, Cullen JP, Cahill PA, Sitzmann JV, Stefansson S,
Lawrence DA, et al. Endothelial cells inhibit flow-induced smooth
muscle cell migration: role of plasminogen activator inhibitor-1. Circu-
lation 2001;103:597-603.
27. Kraiss LW, Weyrich AS, Alto NM, Dixon DA, Ennis TM, Modur V, et
al. Fluid flow activates a regulator of translation, p70/p85 S6 kinase, in
human endothelial cells. Am J Physiol 2000;278:H1537-44.
28. Yun S, Dardik A, Haga M, Yamashita A, Yamaguchi S, Koh Y, et al.
Transcription factor sp1 phosphorylation induced by shear stress inhib-
its membrane type 1-matrix metalloproteinase expression in endothe-
lium. J Biol Chem 2002;277:34808-14.
29. Mills I, Sumpio BE. Vascular smooth muscle cells. In: Sidawy AN,
Sumpio BE, DePalma RL, editors. The basic science of vascular disease.
Futura Publishing Co; 1997. p. 187-226.
30. Zhou H, Li XM, Meinkoth J, Pittman RN. Akt regulates cell survival
and apoptosis at a postmitochondrial level. J Cell Biol 2000;151:483-
94.
31. Wu W, Lee WL, Wu YY, Chen D, Liu TJ, Jang A, et al. Expression of
constitutively active phosphatidylinositol 3-kinase inhibits activation of
Caspase 3 and apoptosis of cardiac muscle cells. J Biol Chem 2000;275:
40113-9.
32. Fujio Y, Walsh K. Akt mediates cytoprotection of endothelial cells by
vascular endothelial growth factor in an anchorage-dependent manner.
J Biol Chem 1999;274:16349-54.
33. Madrid LV, Wang CY, Guttridge DC, Schottelius AJ, Baldwin AS Jr,
Mayo MW. Akt suppreses apoptosis by stimulating the transactivation
potential of the RelA/p65 subunit of NF-KB. Mol Cell Biol 2000;20:
1626-38.
34. Romashkova JA, Makarov SS. NF-KB is a target of AKT in anti-
apoptotic PDGF signaling. Nature 1999;401:86-90.
35. Dimmeler S, Assmus B, Hermann C, Haendeler J, Zeiher AM. Fluid
shear stress stimulates phosphorylation of Akt in human endothelial
cells: involvement in suppression of apoptosis. Circ Res 1998;83:334-
41.
36. Dimmeler S, Fleming I, Fissthaler B, Hermann C, Busse R, Zeiher AM.
Activation of nitric oxide synthase in endothelial cells by Akt-dependent
phosphorylation. Nature 1999;399:601-5.
37. Go YM, Boo YC, Park H, Maland MC, Patel R, Pritchard KA, et al.
Protein kinase B/Akt activates c-Jun NH2-terminal kinase by increasing
NO production in response to shear stress. J Appl Physiol 2001;91:
1574-81.
38. Walker TR, Moore SM, Lawson MF, Panettieri RA Jr, Chilvers ER.
Platelet-derived growth factor-BB and thrombin activate phosphoino-
sitide 3-kinase and protein kinase B: role in mediating airway smooth
muscle proliferation. Mol Pharmacol 1998;54:1007-15.
39. Duan C, Liimatta MB, Bottum OL. Insulin-like growth factor (IGF)-I
regulates IGF-binding protein-5 gene expression through the phospha-
tidylinositol 3-kinase, protein kinase B/Akt, and p70 S6 kinase signal-
ing pathway. J Biol Chem 1999;274:37147-53.
40. Reusch HP, Zimmermann S, Schaefer M, Paul M, Moelling K. Regu-
lation of Raf by Akt controls growth and differentiation in vascular
smooth muscle cells. J Biol Chem 2001;276:33630-7.
41. Sandirasegarane L, Kester M. Enhanced stimulation of Akt-3/protein
kinase B-gamma in human aortic smooth muscle cells. Biochem Bio-
phys Res Commun 2001;283:158-63.
42. Fu M, Zhu X, Wang Q, Zhang J, Song Q, Zheng H, et al. Platelet-
derived growth factor promotes the expression of peroxisome prolifera-
tor-activated receptor gamma in vascular smooth muscle cells by a
phosphatidylinositol 3-kinase/Akt signaling pathway. Circ Res 2001;
89:1058-64.
43. Li XA, Bianchi C, Sellke FW. Rat aortic smooth muscle cell density
affects activation of MAP kinase and Akt by menadione and PDGF
homodimer BB. J Surg Res 2001;100:197-204.
44. Patel NA, Yamamoto M, Illingworth P, Mancu D, Mebert K, Chappell
DS, et al. Phosphoinositide 3-kinase mediates protein kinase C beta II
mRNA destabilization in rat A10 smooth muscle cell cultures exposed
to high glucose. Arch Biochem Biophys 2002;403:111-20.
45. Yamada H, Tsushima T, Murakami H, Uchigata Y, Iwamoto Y. Poten-
tiation of mitogenic activity of platelet-derived growth factor by physi-
ological concentrations of insulin via the MAP kinase cascade in rat A10
vascular smooth muscle cells. Int J Exp Diabetes Res 2002;3:131-44.
46. Dickenson JM. Stimulation of protein kinase B and p70 S6 kinase by the
histamine H1 receptor in DDT1MF-2 smooth muscle cells. Br J Phar-
macol 2002;135:1967-76.
47. Reynolds CM, Eguchi S, Frank GD, Motley ED. Signaling mechanisms
of heparin-binding epidermal growth factor-like growth factor in vas-
cular smooth muscle cells. Hypertension 2002;39:525-9.
48. Sterpetti AV, Cucina A, D’Angelo LS, Cardillo B, Cavallaro A. Shear
stress modulates the proliferation rate, protein synthesis, and mitogenic
activity of arterial smooth muscle cells. Surgery 1993;113:691-9.
49. Walker LN, Bowen-Pope DF, Ross R, Reidy MA. Production of plate-
let-derived growth factor-like molecules by cultured arterial smooth
muscle cells accompanies proliferation after arterial injury. Proc Natl
Acad Sci USA 1986;83:7311-15.
50. Gibbons GH, Pratt RE, Dzau VJ. Vascular smooth muscle cell hyper-
trophy vs. hyperplasia: autocrine transforming growth factor-beta 1
JOURNAL OF VASCULAR SURGERY
Volume 37, Number 6 Haga et al 1283
expression determines growth response to angiotensin II. J Clin Invest
1992;90:456-61.
51. Koyama H, Olson NE, Reidy MA. Cell signaling in injured rat arteries.
Thromb Haemost 1999;82:806-9.
52. Liao DF, Monia B, Dean N, Berk BC. Protein kinase C-zeta mediates
angiotensin II activation of ERK1/2 in vascular smooth muscle cells.
J Biol Chem 1997;272:6146-50.
53. Cho A, Graves J, Reidy MA. Mitogen-activated protein kinases mediate
matrix metalloproteinase-9 expression in vascular smooth muscle cells.
Arterioscler Thromb Vasc Biol 2000;20:2527-32.
54. Force T, Bonventre JV. Growth factors and mitogen-activated protein
kinases. Hypertension 1998;31:152-61.
55. Jung F, Haendeler J, Goebel C, Zeiher AM, Dimmeler S. Growth
factor-induced phosphoinositide 3-OH kinase/Akt phosphorylation in
smooth muscle cells: induction of cell proliferation and inhibition of cell
death. Cardiovasc Res 2000;48:148-57.
56. Coffer PJ, Jin J, Woodgett JR. Protein kinase B (c-Akt): a multifunc-
tional mediator of phosphatidylinositol 3-kinase activation. Biochem J
1998;335:1-13.
57. Datta SR, Brunet A, Greenberg ME. Cellular survival: a play in three
Akts. Genes Dev 1999;13:2905-27.
58. Kandel ES, Hay N. The regulation and activities of the multifunctional
serine/threonine kinase Akt/PKB. Experimental Cell Res 1999;253:
210-29.
59. Dimmeler S, Haendeler J, Rippmann V, Nehls M, Zeiher AM. Shear
stress inhibits apoptosis of human endothelial cells. FEBS Lett 1996;
399:71-4.
60. Rauch BH, Weber AA, Braun M, Zimmermann N, Schror K. PDGF-
induced Akt phosphorylation does not activate NF-B in human vas-
cular smooth muscle cells and fibroblasts. FEBS Lett 2000;481:3-7.
61. Shigematsu K, Koyama H, Olson NE, Cho A, Reidy MA. Phosphati-
dylinositol 3-kinase signaling is important for smooth muscle cell rep-
lication after arterial injury. Arterioscler Thromb Vasc Biol 2000;20:
2373-8.
62. Braun-Ullaeus RC, Mann MJ, Seay U, Zhang L, von der Leyen HE,
Morris RE, et al. Cell cycle protein expression in vascular smooth
muscle cells in vitro and in vivo is regulated through phosphatidylino-
sitol 3-kinase and mammalian target of rapamycin. Arterioscler Thromb
Vasc Biol 2001;21:1152-8.
63. Duan C, Bauchat JR, Hsieh T. Phosphatidylinositol 3-kinase is required
for insulin-like growth factor-I-induced vascular smooth muscle cells
proliferation and migration. Circ Res 2000;86:15-23.
64. Goncharova EA, Ammit AJ, Irani C, Carroll RG, Eszterhas AJ, Panet-
tieri RA, et al. PI3K is required for proliferation and migration of human
pulmonary vascular smooth muscle cells. Am J Physiol 2002;283:L354-
63.
Submitted Oct 11, 2002; accepted Feb 26, 2003.
ANNOUNCING A NEW SECTION: VASCULAR IMAGES
The Vascular Images section presents interesting vascular images and associated short educational summaries in a
focused, case report format. One of the images will be chosen for the cover of each issue of the Journal. Submission
of color illustrations suitable for the Journal cover is encouraged. Appropriate images include radiographs, pathology,
anatomy, operative findings, and other relevant clinical pictures. The images should illustrate features of vascular
disease, including technical approaches. Illustrations and text must be confined to one printed page (no more than
350 words; perhaps less depending on the number and size of illustrations), and images for the cover should possess
both scientific and artistic merit. Descriptions of images must be included in the text, and only key references should
be provided (with a limit of two). Images must be of professional quality and should be provided electronically in
either TIFF or EPS format and uploaded (with the rest of the manuscript) via the Editorial Manager electronic
submission system at http://jvs.editorialmanager.com. Detailed artwork instructions and help with formatting,
sizing, scanning, and file naming can be found at http://www.elsevier.nl/homepage/sab/artwork. A high-
quality print or computer-generated image of each illustration must be submitted to the Journal office for accepted
submissions, even though the illustrations have been submitted previously via Editorial Manager. For more
information regarding hard copy requirements, please see “Guidelines to Complete Submission of an Accepted
Manuscript” at http://jvs.editorialmanager.com.
Contributions for the Vascular Images section are now invited.
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